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Frailty Scores and the
Writing on the Wall*
Todd M. Dewey, MD
Dallas, Texas
The recent interest in frailty as a predictor of poor outcomes
after invasive procedures derives partly from the increasing
use of transcatheter aortic valve replacement (TAVR) in the
treatment of elderly high-risk patients with aortic stenosis.
Historically, many of these patients were either never
referred for therapy, primarily surgical aortic valve replace-
ment, or were summarily turned down after failing the
surgeon’s personal “eyeball” test of operability. That frailty
is now such a hot topic speaks to the fact that the
less-invasive nature of TAVR is bringing more of these patients
into the clinic for evaluation and therapy. Unfortunately, even
See page 489
though TAVR is truly less invasive and provides excellent
hemodynamic results, many patients survive the early post-
operative period only to die within the first year. In the
Cohort A TAVR subset of the PARTNER (Placement of
AoRTic TraNscathetER Valve) trial, an additional 18.5%
of patients that survived the early operative period were dead
within 1 year (1). The concept of frailty and its impact has
been advanced as a possible explanation for the attrition in
survival that occurs after seemingly successful procedures. In
an effort to be more discriminative with regard to which
patients to offer TAVR, clinicians are attempting to con-
ceptualize the many previously recognized stigmata of frailty
in this elderly population.
In this issue of JACC: Cardiovascular Interventions,
Stortecky et al. (2) describe the use of multidimensional
geriatric assessment (MGA) as a tool to predict mortality
and morbidity in a population of 100 patients undergoing
TAVR. Sixty-three patients had a Medtronic CoreValve
(Medtronic, Minneapolis, Minnesota), and 37 patients had
an Edwards Sapien valve (Edwards Lifesciences, Irvine,
California) implanted. The MGA consisted of several
components designed to assess cognitive and functional
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Nutritional Assessment, Timed Get Up and GO, Basic
Activities of Daily Living (BADL), Instrumental Activities
of Daily Living, and intensive interrogation with regard to
mobility. These tests were then made bimodal by inserting
arbitrary cut points that classified test results into probable
or improbable findings of cognitive impairment, malnutri-
tion, or immobility. A numerical value was then assigned to
the outcomes of each test, which were then summed to
provide a combined measure called the frailty index. This
index ranged from 0 to 7 points, with 3 designating
probable frailty.
Additionally, patients had a Society of Thoracic Surgeons
Risk Score (STS Score) and a logistic EuroSCORE calcu-
lated. Patients were stratified on the basis of their risk score.
Higher-risk patients had an STS Score 5% and a logistic
uroSCORE 15%. Lower-risk patients had an STS
core 5% and a logistic EuroSCORE 15%. Outcomes
ere then evaluated on the basis of predicted risk score and
esults of the frailty instruments and frailty index.
Stortecky et al. (2) found that the STS Score showed a
trong association with all-cause mortality and major ad-
erse cardiac and cerebrovascular events (MACCE) at 30
ays and 1 year after TAVR. This outcome is somewhat
nanticipated, because the authors make the case for the
nclusion of frailty testing when evaluating patients for
AVR primarily because the commonly used risk scoring
lgorithms can be relatively inaccurate in this population.
he EuroSCORE was only found to be associated with
-year mortality and MACCE and then only when used as
linear measure. Of the MGA tests, Mini Mental State
xamination, Mini Nutritional Assessment, Timed Get Up
nd GO, BADL, and the frailty index demonstrated an
ssociation with all-cause mortality and MACCE at 30 days
nd 1 year. These various tests were found to be similar in
redictive power to the commonly used risk algorithms. In
his study, only 56% of the patients had an STS Score of
5%, which many would consider only moderate risk at
est. This is also reflected in the fact that less than one-third
f the patients had cognitive impairment or at least 1
imitation of any BADL. Unknown is how many patients
ould be considered high-risk (STS Score8% to 10%) and
hether the impact of frailty scoring is even more predictive
n this cohort of patients. Additionally, it would be instruc-
ive to know whether any 1 of the tests was more specific to
redicting outcomes depending on whether TAVR was
erformed transapically or transfemorally—especially be-
ause these tend to be different groups of patients in terms
f risk factors and outcomes. Further examination of these
ssessments on a larger cohort of patients in a multicenter
tudy will be critical to answering some of these questions.
It is acknowledged that aging and some degree of frailty
enerally go hand in hand. It is important to emphasize,
owever, that frailty and disability are not synonymous—
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498one can be disabled without being frail, and vice versa. The
implications of aging, however, are more than just a num-
bers game. The ability of a patient to tolerate operative
stress depends on many variables, including comorbid ill-
ness, lifelong health habits, nutritional reserve, economic
resources, and psychological resiliency. Many of these com-
bine to account for the intrinsic vigor of patients and their
overall suitability for procedures. Frail patients tend to have
several characteristics in common that directly affect their
ability to recover from surgery: diminished skeletal muscle
mass, poor nutrition, low activity levels, and poor endur-
ance. These factors can predispose patients to numerous
post-operative complications, such as pneumonia or urinary
tract infections. Objectifying these components is the key to
using frailty as a tool for operative decision making.
Incorporating a frailty evaluation into an assessment of
patient risk of morbidity or mortality with surgery promises
to improve patient selection for TAVR. One of the
strengths of the approach taken by Stortecky et al. is that it
tests all the common parameters associated with poor
physiologic reserve—nutrition, cognitive ability, and phys-
ical disability. In contrast, other authors (3) have focused
predominately on measures of physical disability. Incorpo-
rating these tests or other measures of frailty into the
assessment of patients presenting for TAVR offers the
ability to be more discriminate with the technology. Un-
known, however, is what weight to apply to these tests when
evaluating patients. In this study, 49% of the patients were
considered frail by the frailty index of the authors, but the
1-year mortality was only 19%. Therefore, most patients
considered frail did well with surgery and were alive at 1
year. This highlights the challenge with any scoring
method, in that they are useful for gauging risk for large
groups, but each patient has to be assessed individually. In
actual practice, frailty scores are more often used to justify
TAVR rather than conventional surgery. Using frailty scores oto steer patients from conventional surgery to TAVR is
likely to be more effective than using them to deny treat-
ment. Denying treatment that has been shown to be
superior to medical therapy in this population is one of the
more difficult decisions made by clinicians. It generally
incorporates numerous factors, including risk scores, center
or operator experience, and also subjective assessments such
as the “eyeball” test. Whether any patient would be refused
a procedure purely on the basis of a frailty score is unknown
at this point.
The work of Stortecky et al. (2) demonstrates the promise
of frailty scoring in predicting outcomes in a small popula-
tion of patients undergoing TAVR. The limits of TAVR
continue to be explored, particularly with regard to which
patients are too sick or frail for the technology. Frailty
assessment promises to be a key component of either risk
stratification or possibly risk calibration in the evaluation of
these patients.
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